bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplemental Table 2 from Phase IB Dose Escalation and Expansion Study of AKT Inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-resistant Ovarian Cancer
Authors: Blagden Sarah P. , Hamilton Anne L. , Mileshkin Linda , Wong Shirley , Michael Agnieszka , Hall Marcia , Goh Jeffrey C. , Lisyanskaya Alla S. , DeSilvio Michelle , Frangou Eleni , Stronach Euan A. , Gopalakrishna Prashanth , Meniawy Tarek M. , Gabra Hani
Published: April 2023

Study treatment disposition
Supplementary Figures from Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial
Authors: Loibl Sibylle , Treue Denise , Budczies Jan , Weber Karsten , Stenzinger Albrecht , Schmitt Wolfgang D. , Weichert Wilko , Jank Paul , Furlanetto Jenny , Klauschen Frederick , Karn Thomas , Pfarr Nicole , von Minckwitz Gunter , Möbs Markus , Jackisch Christian , Sers Christine , Schneeweiss Andreas , Fasching Peter A. , Schem Christian , Hummel Michael , van Mackelenbergh Marion , Nekljudova Valentina , Untch Michael , Denkert Carsten
Published: April 2023

Supplementary Figures
Table S3 from Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer
Authors: Kraya Adam A. , Maxwell Kara N. , Wubbenhorst Bradley , Wenz Brandon M. , Pluta John , Rech Andrew J. , Dorfman Liza M. , Lunceford Nicole , Barrett Amanda , Mitra Nandita , Morrissette Jennifer J.D. , Feldman Michael , Nayak Anupma , Domchek Susan M. , Vonderheide Robert H. , Nathanson Katherine L.
Published: April 2023

Genes involved in homologous recombination based double strand break DNA repair
Supplementary Data from Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer
Authors: Kraya Adam A. , Maxwell Kara N. , Wubbenhorst Bradley , Wenz Brandon M. , Pluta John , Rech Andrew J. , Dorfman Liza M. , Lunceford Nicole , Barrett Amanda , Mitra Nandita , Morrissette Jennifer J.D. , Feldman Michael , Nayak Anupma , Domchek Susan M. , Vonderheide Robert H. , Nathanson Katherine L.
Published: April 2023

Supplementary Figures S1-S4, Tables S4, S6.
Table S3 from NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer
Authors: Gambardella Valentina , Gimeno-Valiente Francisco , Tarazona Noelia , Ciarpaglini Carolina Martinez , Roda Desamparados , Fleitas Tania , Tolosa Pablo , Cejalvo Juan Miguel , Huerta Marisol , Roselló Susana , Castillo Josefa , Cervantes Andrés
Published: April 2023

List of relevant altered genes in microarray analysis.
Table S2 from NRF2 through RPS6 Activation Is Related to Anti-HER2 Drug Resistance in HER2-Amplified Gastric Cancer
Authors: Gambardella Valentina , Gimeno-Valiente Francisco , Tarazona Noelia , Ciarpaglini Carolina Martinez , Roda Desamparados , Fleitas Tania , Tolosa Pablo , Cejalvo Juan Miguel , Huerta Marisol , Roselló Susana , Castillo Josefa , Cervantes Andrés
Published: April 2023

Primers obtained from PrimerBank database.
Supplementary Data from Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)
Authors: Yuan Chen , Sato Kaori , Hollis Bruce W. , Zhang Sui , Niedzwiecki Donna , Ou Fang-Shu , Chang I-Wen , O'Neil Bert H. , Innocenti Federico , Lenz Heinz-Josef , Blanke Charles D. , Goldberg Richard M. , Venook Alan P. , Mayer Robert J. , Fuchs Charles S. , Meyerhardt Jeffrey A. , Ng Kimmie
Published: April 2023

Supplementary Figure and Table
Supplementary Data Tables from Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab
Authors: Hamid Omid , Molinero Luciana , Bolen Christopher R. , Sosman Jeffrey A. , Muñoz-Couselo Eva , Kluger Harriet M. , McDermott David F. , Powderly John D. , Sarkar Indrani , Ballinger Marcus , Fassò Marcella , O'Hear Carol , Chen Daniel S. , Hegde Priti S. , Hodi F. Stephen
Published: April 2023

Tables S1-S4
Table S3 from Genetic Polymorphisms Predisposing the Interleukin 6–Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations
Authors: Liu Wenbin , Wu Jianfeng , Yang Fan , Ma Longteng , Ni Chong , Hou Xiaomei , Wang Ling , Xu Aijing , Song Jiahui , Deng Yang , Xian Linfeng , Li Zixiong , Wang Shuo , Chen Xi , Yin Jianhua , Han Xue , Li Chengzhong , Zhao Jun , Cao Guangwen
Published: April 2023

Characteristics of participants in the case-control study
Supplementary Figure 11 from Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non–small Cell Lung Cancer
Authors: Salem Ahmed , Little Ross A. , Latif Ayşe , Featherstone Adam K. , Babur Muhammad , Peset Isabel , Cheung Susan , Watson Yvonne , Tessyman Victoria , Mistry Hitesh , Ashton Garry , Behan Caron , Matthews Julian C. , Asselin Marie-Claude , Bristow Robert G. , Jackson Alan , Parker Geoff J.M. , Faivre-Finn Corinne , Williams Kaye J. , O'Connor James P.B.
Published: April 2023

Supplementary Figure 11
Supplementary Table 2 from A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma
Authors: Ramaswami Ramya , Uldrick Thomas S. , Polizzotto Mark N. , Wyvill Kathleen M. , Goncalves Priscila , Widell Anaida , Lurain Kathryn , Steinberg Seth M. , Figg William Douglas , Tosato Giovanna , Whitby Denise , Yarchoan Robert
Published: April 2023

Supplementary Table 2: Analysis of changes in serum VEGF-A and inflammatory cytokines between responders and non-responders after 6 cycles of treatment with bevacizumab and liposomal doxorubicin. *P values are for the difference between responders and non-responders. Abbreviations: IFN, interferon; IL, interleukin; IQR, interquartile range; VEGF, vascular endothelial growth factor
Figure S2 from Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations
Authors: Rodrigues Manuel , Mobuchon Lenha , Houy Alexandre , Alsafadi Samar , Baulande Sylvain , Mariani Odette , Marande Benjamin , Ait Rais Khadija , Van der Kooij Monique K. , Kapiteijn Ellen , Gassama Sieta , Gardrat Sophie , Barnhill Raymond L. , Servois Vincent , Dendale Rémi , Putterman Marc , Tick Sarah , Piperno-Neumann Sophie , Cassoux Nathalie , Pierron Gaëlle , Waterfall Joshua J. , Roman-Roman Sergio , Mariani Pascale , Stern Marc-Henri
Published: April 2023

Supplementary figure 2 - Correlation between metastasis-free survival (MFS) and number of somatic mutations (a.) and CpG>TpG transitions (b.)
Figure S1 from Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations
Authors: Rodrigues Manuel , Mobuchon Lenha , Houy Alexandre , Alsafadi Samar , Baulande Sylvain , Mariani Odette , Marande Benjamin , Ait Rais Khadija , Van der Kooij Monique K. , Kapiteijn Ellen , Gassama Sieta , Gardrat Sophie , Barnhill Raymond L. , Servois Vincent , Dendale Rémi , Putterman Marc , Tick Sarah , Piperno-Neumann Sophie , Cassoux Nathalie , Pierron Gaëlle , Waterfall Joshua J. , Roman-Roman Sergio , Mariani Pascale , Stern Marc-Henri
Published: April 2023

Supplementary figure 1 - Copy number / allelic imbalance profiles of all cases as generated by Facets.
Supplementary Figures S1-10 from Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair
Authors: Wang Xue-Cen , Yue Xin , Zhang Rong-Xin , Liu Ting-Yu , Pan Zhi-Zhong , Yang Meng-Jie , Lu Zhen-Hai , Wang Zi-Yang , Peng Jian-Hong , Le Li-Yuan , Wang Gao-Yuan , Peng Qi-Hua , Meng Yuan , Huang Wenlin , Liu Ran-Yi
Published: April 2023

Supplementary Figure S1 shows the procedure to generate radioresistant HCT1166GyR cells; Supplementary Figure S2 shows reporter constructs of NHEJ and HR pathway; Supplementary Figure S3 shows representative images of IHC assays; Supplementary Figure S4 show the detailed data of screening candidate radioresistant genes; Supplementary Figure S5 shows RFC4 expression in CRC cells and tissues after radiation; Supplementary Figure S6 shows the representative clonogenic pictures for Figure 1C; Supplementary Figure S7 shows representative charts of Annexin V/PI double staining assays for Figure 1F; Supplementary Figure S8 shows the effects of RFC4 on γ-H2AX and pATM levels after radiation; Supplementary Figure S9 shows the additional evidences of RFC4 to promote NHEJ- but not HR-mediate DNA repair; Supplementary Figure S10 shows the effects of RFC4 on the chemotherapeutic drug resistance in HCT116 cells.
Supplementary Table S4 from Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs
Authors: Kiseleva Anna A. , Korobeynikov Vladislav A. , Nikonova Anna S. , Zhang Peishan , Makhov Petr , Deneka Alexander Y. , Einarson Margret B. , Serebriiskii Ilya G. , Liu Hanqing , Peterson Jeffrey R. , Golemis Erica A.
Published: April 2023

Supplementary Table S4. Compounds affecting ciliary dynamics.
Supplementary Table S2 from Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal Cancer
Authors: Lazzari Luca , Corti Giorgio , Picco Gabriele , Isella Claudio , Montone Monica , Arcella Pamela , Durinikova Erika , Zanella Eugenia R. , Novara Luca , Barbosa Fabiane , Cassingena Andrea , Cancelliere Carlotta , Medico Enzo , Sartore-Bianchi Andrea , Siena Salvatore , Garnett Mathew J. , Bertotti Andrea , Trusolino Livio , Di Nicolantonio Federica , Linnebacher Michael , Bardelli Alberto , Arena Sabrina
Published: April 2023

Supplementary Table S2
Supplementary Table S2 from Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
Authors: Klanova Magdalena , Oestergaard Mikkel Z. , Trněný Marek , Hiddemann Wolfgang , Marcus Robert , Sehn Laurie H. , Vitolo Umberto , Bazeos Alexandra , Goede Valentin , Zeuner Harald , Knapp Andrea , Sahin Deniz , Spielewoy Nathalie , Bolen Christopher R. , Cardona Andres , Klein Christian , Venstrom Jeffrey M. , Nielsen Tina , Fingerle-Rowson Günter
Published: April 2023

Risk or severity of IRRs by NKCC (A) and by NKCC and treatment arm (B) in FL and DLBCL.
Supplementary Figure S1 from Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
Authors: Klanova Magdalena , Oestergaard Mikkel Z. , Trněný Marek , Hiddemann Wolfgang , Marcus Robert , Sehn Laurie H. , Vitolo Umberto , Bazeos Alexandra , Goede Valentin , Zeuner Harald , Knapp Andrea , Sahin Deniz , Spielewoy Nathalie , Bolen Christopher R. , Cardona Andres , Klein Christian , Venstrom Jeffrey M. , Nielsen Tina , Fingerle-Rowson Günter
Published: April 2023

Distribution of baseline peripheral blood NKCCa in FL and DLBCL patients for the GALLIUM and GOYAb ITT populations (A) and by COO subtype in DLBCL (B).
Supplementary Figures from A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection
Authors: Hess Julia , Unger Kristian , Maihoefer Cornelius , Schüttrumpf Lars , Wintergerst Ludmila , Heider Theresa , Weber Peter , Marschner Sebastian , Braselmann Herbert , Samaga Daniel , Kuger Sebastian , Pflugradt Ulrike , Baumeister Philipp , Walch Axel , Woischke Christine , Kirchner Thomas , Werner Martin , Werner Kristin , Baumann Michael , Budach Volker , Combs Stephanie E. , Debus Jürgen , Grosu Anca-Ligia , Krause Mechthild , Linge Annett , Rödel Claus , Stuschke Martin , Zips Daniel , Zitzelsberger Horst , Ganswindt Ute , Henke Michael , Belka Claus
Published: April 2023

Supplementary Figures 1-20
Supplementary Data from T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells
Authors: Lapteva Natalia , Gilbert Margaret , Diaconu Iulia , Rollins Lisa A. , Al-Sabbagh Mina , Naik Swati , Krance Robert A. , Tripic Tamara , Hiregange Manasa , Raghavan Darshana , Dakhova Olga , Rouce Rayne H. , Liu Hao , Omer Bilal , Savoldo Barbara , Dotti Gianpietro , Cruz Conrad Russel , Sharpe Keli , Gates Melissa , Orozco Aaron , Durett April , Pacheco Elizabeth , Gee Adrian P. , Ramos Carlos A. , Heslop Helen E. , Brenner Malcolm K. , Rooney Cliona M.
Published: April 2023

Supplementary Data
Supplemental Table 2 from Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate
Authors: Lee Oukseub , Sullivan Megan E. , Xu Yanfei , Rogers Chiara , Muzzio Miguel , Helenowski Irene , Shidfar Ali , Zeng Zexian , Singhal Hari , Jovanovic Borko , Hansen Nora , Bethke Kevin P. , Gann Peter H. , Gradishar William , Kim J. Julie , Clare Susan E. , Khan Seema A.
Published: April 2023

Supplemental table 2. Differential gene expression and pathway enrichment analysis in placebo responders (excel file) -uploading separately.
Supplementary Table S6 from Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-κB Signaling
Authors: Ji Jianxiong , Xu Ran , Ding Kaikai , Bao Guoqing , Zhang Xin , Huang Bin , Wang Xinyu , Martinez Aurora , Wang Xiuying , Li Gang , Miletic Hrvoje , Thorsen Frits , Bjerkvig Rolf , Xiang Lei , Han Bo , Chen Anjing , Li Xingang , Wang Jian
Published: April 2023

Proteins binding with SChLAP1 sense and antisense
Supplementary Information from Dose Optimization for Anticancer Drug Combinations: Maximizing Therapeutic Index via Clinical Exposure-Toxicity/Preclinical Exposure-Efficacy Modeling
Authors: Bottino Dean C. , Patel Mayankbhai , Kadakia Ekta , Zhou Jilai , Patel Chirag , Neuwirth Rachel , Iartchouk Natasha , Brake Rachael , Venkatakrishnan Karthik , Chakravarty Arijit
Published: April 2023

Supplementary Methods, Figures S1-5, and Tables S1-3
Supplementary Data from Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma
Authors: Yu Jiayi , Yan Junya , Guo Qian , Chi Zhihong , Tang Bixia , Zheng Bin , Yu Jinyu , Yin Ting , Cheng Zhiyuan , Wu Xiaowen , Yu Huan , Dai Jie , Sheng Xinan , Si Lu , Cui Chuanliang , Bai Xue , Mao Lili , Lian Bin , Wang Xuan , Yan Xieqia , Li Siming , Zhou Li , Flaherty Keith T. , Guo Jun , Kong Yan
Published: April 2023

Supplementary Data Supplementary Table S1.Clinical pathological parameters of enrolled patients Supplementary Table S2. The sample information of QuantiGenePlex RNA assay Supplementary Table S3. Correlation of CDK4 pathway aberrations withPD-L1 protein expression in melanoma patients.
Figure S3 from Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma
Authors: Yu Jiayi , Yan Junya , Guo Qian , Chi Zhihong , Tang Bixia , Zheng Bin , Yu Jinyu , Yin Ting , Cheng Zhiyuan , Wu Xiaowen , Yu Huan , Dai Jie , Sheng Xinan , Si Lu , Cui Chuanliang , Bai Xue , Mao Lili , Lian Bin , Wang Xuan , Yan Xieqia , Li Siming , Zhou Li , Flaherty Keith T. , Guo Jun , Kong Yan
Published: April 2023

Supplementary Figure S3. CDK4/6 inhibitor treatment positively regulates PD-L1 protein expression and influences immune gene expression.
Supplementary Figures from Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-κB Signaling
Authors: Ji Jianxiong , Xu Ran , Ding Kaikai , Bao Guoqing , Zhang Xin , Huang Bin , Wang Xinyu , Martinez Aurora , Wang Xiuying , Li Gang , Miletic Hrvoje , Thorsen Frits , Bjerkvig Rolf , Xiang Lei , Han Bo , Chen Anjing , Li Xingang , Wang Jian
Published: April 2023

Supplementary Figures S1-S7
Cancer-infiltrated sweep from AI-Assisted In Situ Detection of Human Glioma Infiltration Using a Novel Computational Method for Optical Coherence Tomography
Authors: Juarez-Chambi Ronald M. , Kut Carmen , Rico-Jimenez Jose J. , Chaichana Kaisorn L. , Xi Jiefeng , Campos-Delgado Daniel U. , Rodriguez Fausto J. , Quinones-Hinojosa Alfredo , Li Xingde , Jo Javier A.
Published: April 2023

Sweep animation for a predicted cancer-infiltrated OCT volume
Cancer-infiltrated rotation from AI-Assisted In Situ Detection of Human Glioma Infiltration Using a Novel Computational Method for Optical Coherence Tomography
Authors: Juarez-Chambi Ronald M. , Kut Carmen , Rico-Jimenez Jose J. , Chaichana Kaisorn L. , Xi Jiefeng , Campos-Delgado Daniel U. , Rodriguez Fausto J. , Quinones-Hinojosa Alfredo , Li Xingde , Jo Javier A.
Published: April 2023

Rotation animation of a predicted cancer-infiltrated OCT volume
Cancer-free sweep from AI-Assisted In Situ Detection of Human Glioma Infiltration Using a Novel Computational Method for Optical Coherence Tomography
Authors: Juarez-Chambi Ronald M. , Kut Carmen , Rico-Jimenez Jose J. , Chaichana Kaisorn L. , Xi Jiefeng , Campos-Delgado Daniel U. , Rodriguez Fausto J. , Quinones-Hinojosa Alfredo , Li Xingde , Jo Javier A.
Published: April 2023

Sweep animation for a predicted cancer-free OCT volume
Cancer-free rotation from AI-Assisted In Situ Detection of Human Glioma Infiltration Using a Novel Computational Method for Optical Coherence Tomography
Authors: Juarez-Chambi Ronald M. , Kut Carmen , Rico-Jimenez Jose J. , Chaichana Kaisorn L. , Xi Jiefeng , Campos-Delgado Daniel U. , Rodriguez Fausto J. , Quinones-Hinojosa Alfredo , Li Xingde , Jo Javier A.
Published: April 2023

Rotation animation of a predicted cancer-free OCT volume
Supplementary Figure 5 from Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia–Related Head and Neck Cancer
Authors: Montanuy Helena , Martínez-Barriocanal Águeda , Antonio Casado José , Rovirosa Llorenç , Ramírez Maria José , Nieto Rocío , Carrascoso-Rubio Carlos , Riera Pau , González Alan , Lerma Enrique , Lasa Adriana , Carreras-Puigvert Jordi , Helleday Thomas , Bueren Juan A. , Arango Diego , Minguillón Jordi , Surrallés Jordi
Published: April 2023

Figure S5. FACS gating strategy to analyze white blood cell population in WT and Fanca-deficient mice.
Supplementary Table 6 from Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer
Authors: Huang Lei , David Odile , Cabay Robert J. , Valyi-Nagy Klara , Macias Virgilia , Zhong Rong , Wenig Barry , Feldman Lawrence , Weichselbaum Ralph , Spiotto Michael T.
Published: April 2023

Supplemental Table 6: mRNA:miRNA pairs enriched in LNMs subtypes.
Table S3 from Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma
Authors: Yan Zi-Xun , Li Li , Wang Wen , OuYang Bin-Shen , Cheng Shu , Wang Li , Wu Wen , Xu Peng-Peng , Muftuoglu Muharrem , Hao Ming , Yang Su , Zhang Mu-Chen , Zheng Zhong , Li James , Zhao Wei-Li
Published: April 2023

Supplementary Table S3: Adverse Events
Supplementary Table 2 from Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer
Authors: Huang Lei , David Odile , Cabay Robert J. , Valyi-Nagy Klara , Macias Virgilia , Zhong Rong , Wenig Barry , Feldman Lawrence , Weichselbaum Ralph , Spiotto Michael T.
Published: April 2023

Supplemental Table 2. LN classification by iCluster and PAM classifier.
Table S1 from Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma
Authors: Yan Zi-Xun , Li Li , Wang Wen , OuYang Bin-Shen , Cheng Shu , Wang Li , Wu Wen , Xu Peng-Peng , Muftuoglu Muharrem , Hao Ming , Yang Su , Zhang Mu-Chen , Zheng Zhong , Li James , Zhao Wei-Li
Published: April 2023

Supplementary Table S1: The sequences of PCR primers
Supplementary Table 4 from Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types
Authors: Chen William S. , Alshalalfa Mohammed , Zhao Shuang G. , Liu Yang , Mahal Brandon A. , Quigley David A. , Wei Ting , Davicioni Elai , Rebbeck Timothy R. , Kantoff Philip W. , Maher Christopher A. , Knudsen Karen E. , Small Eric J. , Nguyen Paul L. , Feng Felix Y.
Published: April 2023

Tumor suppressors selected for methylation analysis null model
Figure S1 from A Constitutional Activating MET Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases
Authors: El Bouchtaoui Morad , Do Cruzeiro Marcio , Leboeuf Christophe , Loisel-Ferreira Irmine , Fedronie Carèle , Ferreira Chrystophe , Ait El Far Rachida , Ziol Marianne , Espié Marc , Falgarone Géraldine , Cassinat Bruno , Kiladjian Jean-Jacques , Feugeas Jean-Paul , Janin Anne , Bousquet Guilhem
Published: April 2023

Supplementary Figure S1
Supplementary Data from Multidrug Cancer Therapy in Metastatic Castrate-Resistant Prostate Cancer: An Evolution-Based Strategy
Authors: West Jeffrey B. , Dinh Mina N. , Brown Joel S. , Zhang Jingsong , Anderson Alexander R. , Gatenby Robert A.
Published: April 2023

Supplementary material
Supplementary Figure 2 from Expression of AR-V7 and ARv567es in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY
Authors: Tagawa Scott T. , Antonarakis Emmanuel S. , Gjyrezi Ada , Galletti Giuseppe , Kim Seaho , Worroll Daniel , Stewart John , Zaher Atef , Szatrowski Ted P. , Ballman Karla V. , Kita Katsuhiro , Tasaki Shinsuke , Bai Yang , Portella Luigi , Kirby Brian J. , Saad Fred , Eisenberger Mario A. , Nanus David M. , Giannakakou Paraskevi
Published: April 2023

AR-FL and AR-V expression in healthy donor blood run through the GEDI device. The mRNA expression levels of AR-FL (blue), AR-v7 (red) and AR-v567es (green) were analyzed in healthy donor blood from 10 volunteers. As previously described, 1 mL of healthy donor peripheral blood was processed through the GEDI microfluidic device. The table below the graph shows the raw data (copy number) for each transcript per sample. AR, androgen receptor; ddPCR, droplet digital polymerase chain reaction; FL, full length; GEDI, geometrically enhanced differential immunocapture; mRNA, messenger ribonucleic acid.
Figure S3 from Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL–Induced B-Cell Acute Lymphoblastic Leukemia
Authors: Yang Linyu , Qiu Qiang , Tang Minghai , Wang Fang , Yi Yuyao , Yi Dongni , Yang Zhuang , Zhu Zejiang , Zheng Shoujun , Yang Jianhong , Pei Heying , Zheng Li , Chen Yong , Gou Liping , Luo Liya , Deng Xing , Ye Haoyu , Hu Yiguo , Niu Ting , Chen Lijuan
Published: April 2023

Toxicity studies of PM.
Supplementary Data from BRN4 Is a Novel Driver of Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer and Is Selectively Released in Extracellular Vesicles with BRN2
Authors: Bhagirath Divya , Yang Thao Ly , Tabatabai Z. Laura , Majid Shahana , Dahiya Rajvir , Tanaka Yuichiro , Saini Sharanjot
Published: April 2023

Table S1 Clinicopathologic characteristics of metastatic CRPC patients (Cohort 1+2)
Suppl Table 1 from AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival
Authors: Cosimo Emilio , Tarafdar Anuradha , Moles Michael W. , Holroyd Ailsa K. , Malik Natasha , Catherwood Mark A. , Hay Jodie , Dunn Karen M. , Macdonald Alan M. , Guichard Sylvie M. , O'Rourke Declan , Leach Michael T. , Sansom Owen J. , Cosulich Sabina C. , McCaig Alison M. , Michie Alison M.
Published: April 2023

Suppl Table 1
Supplementary Data from Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides
Authors: O'Malley John T. , de Masson Adele , Lowry Elizabeth L. , Giobbie-Hurder Anita , LeBoeuf Nicole R. , Larocca Cecilia , Gehad Ahmed , Seger Edward , Teague Jessica E. , Fisher David C. , Kupper Thomas S. , Devlin Phillip M. , Clark Rachael A.
Published: April 2023

Figure S1
Supplementary Figure 2 from Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma
Authors: Chen Robert , Herrera Alex F. , Hou Jessie , Chen Lu , Wu Jun , Guo Yuming , Synold Timothy W. , Ngo Vu N. , Puverel Sandrine , Mei Matthew , Popplewell Leslie , Yi Shuhua , Song Joo Y. , Tao Shu , Wu Xiwei , Chan Wing C. , Forman Stephen J. , Kwak Larry W. , Rosen Steven T. , Newman Edward M.
Published: April 2023

Supplementary Figure 2
Figure S2 from A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma
Authors: Mita Monica M. , LoRusso Patricia M. , Papadopoulos Kyriakos P. , Gordon Michael S. , Mita Alain C. , Ferraldeschi Roberta , Keer Harold , Oganesian Aram , Su Xiang Yao , Jueliger Simone , Tolcher Anthony W.
Published: April 2023

Figure S2 shows changes in interleukin-6 in plasma from screening thru day 9 at the indicated doses.
Supplementary Data from Detection of Circulating and Disseminated Neuroblastoma Cells Using the ImageStream Flow Cytometer for Use as Predictive and Pharmacodynamic Biomarkers
Authors: Merugu Swathi , Chen Lindi , Gavens Elizabeth , Gabra Hany , Brougham Mark , Makin Guy , Ng Antony , Murphy Dermot , Gabriel Alem S. , Robinson Michael L. , Wright Jennifer H. , Burchill Susan A. , Humphreys Angharad , Bown Nick , Jamieson David , Tweddle Deborah A.
Published: April 2023

Supplementary Tables and Figures
Supplementary Figure 1 from Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases
Authors: Kawaguchi Yoshikuni , Kopetz Scott , Newhook Timothy E. , De Bellis Mario , Chun Yun Shin , Tzeng Ching-Wei D. , Aloia Thomas A. , Vauthey Jean-Nicolas
Published: April 2023

Supplementary Figure 1. Patient selection
Table S3 from Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy
Authors: Xie Feng , Zhang Jianjun , Wang Jiayin , Reuben Alexandre , Xu Wei , Yi Xin , Varn Frederick S. , Ye Yongsheng , Cheng Junwen , Yu Miao , Wang Yue , Liu Yufeng , Xie Mingchao , Du Peng , Ma Ke , Ma Xin , Zhou Penghui , Yang Shengli , Chen Yaobing , Wang Guoping , Xia Xuefeng , Liao Zhongxing , Heymach John V. , Wistuba Ignacio I. , Futreal P. Andrew , Ye Kai , Cheng Chao , Xia Tian
Published: April 2023

Table S3 describes multivariate Cox regression analysis of variables in Van Allen's and Snyder's patients.
Supplementary Methods, Figure Legends, Refs from Comprehensive Profiling of Poor-Risk Paired Primary and Recurrent Triple-Negative Breast Cancers Reveals Immune Phenotype Shifts
Authors: Hutchinson Katherine E. , Yost Susan E. , Chang Ching-Wei , Johnson Radia Marie , Carr Adrian R. , McAdam Paul R. , Halligan Daniel L. , Chang Chun-Chieh , Schmolze Daniel , Liang Jackson , Yuan Yuan
Published: April 2023

Supplementary Methods, Figure Legends, and References
Figure S06 from Comprehensive Profiling of Poor-Risk Paired Primary and Recurrent Triple-Negative Breast Cancers Reveals Immune Phenotype Shifts
Authors: Hutchinson Katherine E. , Yost Susan E. , Chang Ching-Wei , Johnson Radia Marie , Carr Adrian R. , McAdam Paul R. , Halligan Daniel L. , Chang Chun-Chieh , Schmolze Daniel , Liang Jackson , Yuan Yuan
Published: April 2023

Correlations between immune gene signature scores and TILs
Table S1 from Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma
Authors: Gartrell Robyn D. , Marks Douglas K. , Rizk Emanuelle M. , Bogardus Margaret , Gérard Camille L. , Barker Luke W. , Fu Yichun , Esancy Camden L. , Li Gen , Ji Jiayi , Rui Shumin , Ernstoff Marc S. , Taback Bret , Pabla Sarabjot , Chang Rui , Lee Sandra J. , Krolewski John J. , Morrison Carl , Horst Basil A. , Saenger Yvonne M.
Published: April 2023

Comparison of patient demographics in validation cohort to original publication discovery and test cohorts.
Figure S01 from Comprehensive Profiling of Poor-Risk Paired Primary and Recurrent Triple-Negative Breast Cancers Reveals Immune Phenotype Shifts
Authors: Hutchinson Katherine E. , Yost Susan E. , Chang Ching-Wei , Johnson Radia Marie , Carr Adrian R. , McAdam Paul R. , Halligan Daniel L. , Chang Chun-Chieh , Schmolze Daniel , Liang Jackson , Yuan Yuan
Published: April 2023

Flow chart of samples and analyses performed in the study.
Figure S1 from Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma
Authors: Gartrell Robyn D. , Marks Douglas K. , Rizk Emanuelle M. , Bogardus Margaret , Gérard Camille L. , Barker Luke W. , Fu Yichun , Esancy Camden L. , Li Gen , Ji Jiayi , Rui Shumin , Ernstoff Marc S. , Taback Bret , Pabla Sarabjot , Chang Rui , Lee Sandra J. , Krolewski John J. , Morrison Carl , Horst Basil A. , Saenger Yvonne M.
Published: April 2023

Melanoma Immune Profile (MIP) correlates with metastasis cohort including patients with local recurrence only.
Figure S2 from Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial
Authors: Bernard-Tessier Alice , Jeannot Emmanuelle , Guenat David , Debernardi Alice , Michel Marc , Proudhon Charlotte , Vincent-Salomon Anne , Bièche Ivan , Pierga Jean-Yves , Buecher Bruno , Meurisse Aurélia , François Éric , Cohen Romain , Jary Marine , Vendrely Véronique , Samalin Emmanuelle , El Hajbi Farid , Baba-Hamed Nabil , Borg Christophe , Bidard François-Clément , Kim Stefano
Published: April 2023

Figure S2 shows the ROC curve analysis of progression prediction according to the HPV ctDNA level at baseline. (AUC was 0.646 (95% CI 0.49 to 0.802) and 2940 copies/ml was determined as the ctDNA cut-off level for comparison. Sensitivity and specificity of the cut-off were 67% and 70% respectively).
Supplementary Figure 3 from Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Authors: Capdevila Jaume , Arqués Oriol , Hernández Mora Jose Ramón , Matito Judit , Caratù Ginevra , Mancuso Francesco M. , Landolfi Stefania , Barriuso Jorge , Jimenez-Fonseca Paula , Lopez Lopez Carlos , Garcia-Carbonero Rocio , Hernando Jorge , Matos Ignacio , Paolo Nuciforo , Hernández-Losa Javier , Esteller Manel , Martínez-Cardús Anna , Tabernero Josep , Vivancos Ana , Palmer Héctor G.
Published: April 2023

Supplementary Figure 3
Supplementary Data from Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer
Authors: Seiler Roland , Gibb Ewan A. , Wang Natalie Q. , Oo Htoo Zarni , Lam Hung-Ming , van Kessel Kim E. , Voskuilen Charlotte S. , Winters Brian , Erho Nicholas , Takhar Mandeep M. , Douglas James , Vakar-Lopez Funda , Crabb Simon J. , van Rhijn Bas W.G. , Fransen van de Putte Elisabeth E. , Zwarthoff Ellen C. , Thalmann George N. , Davicioni Elai , Boormans Joost L. , Dall'Era Marc , van der Heijden Michiel S. , Wright Jonathan L. , Black Peter C.
Published: April 2023

Table S1-S5 Figures S1-10
Supplementary Table S2 from Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
Authors: Meric-Bernstam Funda , Johnson Amber M. , Dumbrava Ecaterina E. Ileana , Raghav Kanwal , Balaji Kavitha , Bhatt Michelle , Murthy Rashmi K. , Rodon Jordi , Piha-Paul Sarina A.
Published: April 2023

Activating HER2 mutations and their frequencies
Supplemental legend from Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer
Authors: Aggarwal Charu , Cohen Roger B. , Morrow Matthew P. , Kraynyak Kimberly A. , Sylvester Albert J. , Knoblock Dawson M. , Bauml Joshua M. , Weinstein Gregory S. , Lin Alexander , Boyer Jean , Sakata Lindsay , Tan Sophie , Anton Aubrey , Dickerson Kelsie , Mangrolia Drishty , Vang Russell , Dallas Michael , Oyola Sandra , Duff Susan , Esser Mark , Kumar Rakesh , Weiner David , Csiki Ildiko , Bagarazzi Mark L.
Published: April 2023

Supplemental legend
Supplementary Table S1 from Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
Authors: Meric-Bernstam Funda , Johnson Amber M. , Dumbrava Ecaterina E. Ileana , Raghav Kanwal , Balaji Kavitha , Bhatt Michelle , Murthy Rashmi K. , Rodon Jordi , Piha-Paul Sarina A.
Published: April 2023

Supplementary Table S1. FDA approved HER2-targeted therapies
Supplementary Table 6 from Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer
Authors: Rashid Naim U. , Peng Xianlu L. , Jin Chong , Moffitt Richard A. , Volmar Keith E. , Belt Brian A. , Panni Roheena Z. , Nywening Timothy M. , Herrera Silvia G. , Moore Kristin J. , Hennessey Sarah G. , Morrison Ashley B. , Kawalerski Ryan , Nayyar Apoorve , Chang Audrey E. , Schmidt Benjamin , Kim Hong Jin , Linehan David C. , Yeh Jen Jen
Published: April 2023

Table S6
Figure S6 from IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Authors: Conlon Kevin C. , Potter E. Lake , Pittaluga Stefania , Lee Chyi-Chia Richard , Miljkovic Milos D. , Fleisher Thomas A. , Dubois Sigrid , Bryant Bonita R. , Petrus Michael , Perera Liyanage P. , Hsu Jennifer , Figg William D. , Peer Cody J. , Shih Joanna H. , Yovandich Jason L. , Creekmore Stephen P. , Roederer Mario , Waldmann Thomas A.
Published: April 2023

Supplementary Figure S6
Figure S1 from BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies
Authors: Poh Weijie , Dilley Robert L. , Moliterno Alison R. , Maciejewski Jaroslaw P. , Pratz Keith W. , McDevitt Michael A. , Herman James G.
Published: April 2023

Figure S1 shows the percentage of γH2AX- and RAD51- foci positive cells with and without radiation.
Supplementary Figure S4 from Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma
Authors: Mitani Yoshitsugu , Lin Sue-Hwa , Pytynia Kristen B. , Ferrarotto Renata , El-Naggar Adel K.
Published: April 2023

BCL2 and PHLPP1 expressions after GR knockdown.
Table S2 from Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
Authors: Binzer-Panchal Amrei , Hardell Elin , Viklund Björn , Ghaderi Mehran , Bosse Tjalling , Nucci Marisa R. , Lee Cheng-Han , Hollfelder Nina , Corcoran Pádraic , Gonzalez-Molina Jordi , Moyano-Galceran Lidia , Bell Debra A. , Schoolmeester John K. , Måsbäck Anna , Kristensen Gunnar B. , Davidson Ben , Lehti Kaisa , Isaksson Anders , Carlson Joseph W.
Published: April 2023

Table S2
Figure S3 from Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression
Authors: Bernard Vincent , Semaan Alexander , Huang Jonathan , San Lucas F. Anthony , Mulu Feven C. , Stephens Bret M. , Guerrero Paola A. , Huang Yanqing , Zhao Jun , Kamyabi Nabiollah , Sen Subrata , Scheet Paul A. , Taniguchi Cullen M. , Kim Michael P. , Tzeng Ching-Wei , Katz Matthew H. , Singhi Aatur D. , Maitra Anirban , Alvarez Hector A.
Published: April 2023

Feature Plot of characteristic genes plotted across tSNE clusters demonstrating stromal phenotypes.
Supplementary Scheme 1 from Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Authors: Juthani Rupa , Madajewski Brian , Yoo Barney , Zhang Li , Chen Pei-Ming , Chen Feng , Turker Melik Z. , Ma Kai , Overholtzer Michael , Longo Valerie A. , Carlin Sean , Aragon-Sanabria Virginia , Huse Jason , Gonen Mithat , Zanzonico Pat , Rudin Charles M. , Wiesner Ulrich , Bradbury Michelle S. , Brennan Cameron W.
Published: April 2023

Scheme depicting the experimental approach for in vivo studies
Supplemental Video 1b from Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Authors: Juthani Rupa , Madajewski Brian , Yoo Barney , Zhang Li , Chen Pei-Ming , Chen Feng , Turker Melik Z. , Ma Kai , Overholtzer Michael , Longo Valerie A. , Carlin Sean , Aragon-Sanabria Virginia , Huse Jason , Gonen Mithat , Zanzonico Pat , Rudin Charles M. , Wiesner Ulrich , Bradbury Michelle S. , Brennan Cameron W.
Published: April 2023

Supplemental Video 1b from Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Supplemental Video 1a from Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Authors: Juthani Rupa , Madajewski Brian , Yoo Barney , Zhang Li , Chen Pei-Ming , Chen Feng , Turker Melik Z. , Ma Kai , Overholtzer Michael , Longo Valerie A. , Carlin Sean , Aragon-Sanabria Virginia , Huse Jason , Gonen Mithat , Zanzonico Pat , Rudin Charles M. , Wiesner Ulrich , Bradbury Michelle S. , Brennan Cameron W.
Published: April 2023

Supplemental Video 1a from Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Figure S5 from lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP
Authors: Li Nan , Yang Guohua , Luo Liyun , Ling Li , Wang Xiaorong , Shi Lejuan , Lan Junsong , Jia Xiaoting , Zhang Qiong , Long Ze , Liu Jinbao , Hu Weimin , He Zhimin , Liu Haiying , Liu Wanqing , Zheng Guopei
Published: April 2023

Figure S5, related to Figure 5. THAP9-AS1 interacts with YAP to block LATS1-mediated YAP phosphorylation.
Supplemental Figure 5 from Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Authors: Juthani Rupa , Madajewski Brian , Yoo Barney , Zhang Li , Chen Pei-Ming , Chen Feng , Turker Melik Z. , Ma Kai , Overholtzer Michael , Longo Valerie A. , Carlin Sean , Aragon-Sanabria Virginia , Huse Jason , Gonen Mithat , Zanzonico Pat , Rudin Charles M. , Wiesner Ulrich , Bradbury Michelle S. , Brennan Cameron W.
Published: April 2023

Images of p-S6RP IHC performed on additional treatment and control mouse brain tissues
Supplemental Figure 3 from Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Authors: Juthani Rupa , Madajewski Brian , Yoo Barney , Zhang Li , Chen Pei-Ming , Chen Feng , Turker Melik Z. , Ma Kai , Overholtzer Michael , Longo Valerie A. , Carlin Sean , Aragon-Sanabria Virginia , Huse Jason , Gonen Mithat , Zanzonico Pat , Rudin Charles M. , Wiesner Ulrich , Bradbury Michelle S. , Brennan Cameron W.
Published: April 2023

Synthesis scheme of cRGDY-Das-NDCs
Supplemental Figure 1 from Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model
Authors: Juthani Rupa , Madajewski Brian , Yoo Barney , Zhang Li , Chen Pei-Ming , Chen Feng , Turker Melik Z. , Ma Kai , Overholtzer Michael , Longo Valerie A. , Carlin Sean , Aragon-Sanabria Virginia , Huse Jason , Gonen Mithat , Zanzonico Pat , Rudin Charles M. , Wiesner Ulrich , Bradbury Michelle S. , Brennan Cameron W.
Published: April 2023

Cellular binding and internalization of cRGD-C' dots in glioma cells
Table S1 from Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy
Authors: Hai Josephine , Zhang Hua , Zhou Jin , Wu Zhong , Chen Ting , Papadopoulos Eleni , Dowling Catríona M. , Pyon Val , Pan Yuanwang , Liu Jie Bin , Bronson Roderick T. , Silver Heather , Lizotte Patrick H. , Deng Jiehui , Campbell Joshua D. , Sholl Lynette M. , Ng Christine , Tsao Ming-Sound , Thakurdin Cassandra , Bass Adam J. , Wong Kwok-Kin
Published: April 2023

Cell lines models
Supplementary Figures S1-9 from Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy
Authors: Hai Josephine , Zhang Hua , Zhou Jin , Wu Zhong , Chen Ting , Papadopoulos Eleni , Dowling Catríona M. , Pyon Val , Pan Yuanwang , Liu Jie Bin , Bronson Roderick T. , Silver Heather , Lizotte Patrick H. , Deng Jiehui , Campbell Joshua D. , Sholl Lynette M. , Ng Christine , Tsao Ming-Sound , Thakurdin Cassandra , Bass Adam J. , Wong Kwok-Kin
Published: April 2023

Figures S1-9
Supplementary Data from Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease
Authors: Nguyen Hung , Alawieh Ali , Bastian David , Kuril Sandeepkumar , Dai Min , Daenthanasanmak Anusara , Zhang Mengmeng , Iamsawat Supinya , Schutt Steven D. , Wu Yongxia , Sleiman M. Mahdi , Shetty Akshay , Atkinson Carl , Sun Shaoli , Varela Juan Carlos , Tomlinson Stephen , Yu Xue-Zhong
Published: April 2023

Supplemental Materials
Table S2 from Intertumoral Heterogeneity of CD3+ and CD8+ T-Cell Densities in the Microenvironment of DNA Mismatch-Repair–Deficient Colon Cancers: Implications for Prognosis
Authors: Yoon Harry H. , Shi Qian , Heying Erica N. , Muranyi Andrea , Bredno Joerg , Ough Faith , Djalilvand Azita , Clements June , Bowermaster Rebecca , Liu Wen-Wei , Barnes Michael , Alberts Steven R. , Shanmugam Kandavel , Sinicrope Frank A.
Published: April 2023

Table S2: Association between immune T-cell subtypes in MMR-deficient and -proficient stage III colon cancers.
FigureS4 from Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8+ T-Cell–Dependent Tumor Activity
Authors: Watanabe Tsubasa , Gaedicke Simone , Guffart Elena , Firat Elke , Niedermann Gabriele
Published: April 2023

Supplementary Figure 4
FigureS3 from Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8+ T-Cell–Dependent Tumor Activity
Authors: Watanabe Tsubasa , Gaedicke Simone , Guffart Elena , Firat Elke , Niedermann Gabriele
Published: April 2023

Supplementary Figure 3
FigureS2 from Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8+ T-Cell–Dependent Tumor Activity
Authors: Watanabe Tsubasa , Gaedicke Simone , Guffart Elena , Firat Elke , Niedermann Gabriele
Published: April 2023

Supplementary Figure 2
Supplementary Data from Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma
Authors: Tang Bingtao , Guo Zong Sheng , Bartlett David L. , Yan David Z. , Schane Claire P. , Thomas Diana L. , Liu Jia , McFadden Grant , Shisler Joanna L. , Roy Edward J.
Published: April 2023

IHC, survival curve, celecoxib, H&E
Supplementary Data from A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations
Authors: Voss Martin H. , Hierro Cinta , Heist Rebecca S. , Cleary James M. , Meric-Bernstam Funda , Tabernero Josep , Janku Filip , Gandhi Leena , Iafrate A. John , Borger Darrell R. , Ishii Nobuya , Hu Youyou , Kirpicheva Yulia , Nicolas-Metral Valerie , Pokorska-Bocci Anna , Vaslin Chessex Anne , Zanna Claudio , Flaherty Keith T. , Baselga Jose
Published: April 2023

Supplemental tables, figures, and methods
Supplementary Data 3 from A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma
Authors: Ghobrial Irene M. , Liu Chia-Jen , Redd Robert A. , Perez Raymond P. , Baz Rachid , Zavidij Oksana , Sklavenitis-Pistofidis Romanos , Richardson Paul G. , Anderson Kenneth C. , Laubach Jacob , Henrick Patrick , Savell Alexandra , Reyes Kaitlen , Hornburg Kalvis , Chuma Stacey , Sabbatini Peter , Robbins Michael D. , Becker Pamela S.
Published: April 2023

This figure shows (A) Proportion of circulating CD34+ stem cells (% of living cells, all patients combined). (B) Proportion of circulating CD138+ myeloma cells (% of living cells, all patients combined) (C) Distribution of CD34+ stem cells in responding vs. non-responding group (% of living cells). (D) Distribution of CD138+ myeloma cells in responding vs. non-responding group (% of living cells).
Table S6 from Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
Authors: Flores-Morales Amilcar , Bergmann Tobias B. , Lavallee Charlotte , Batth Tanveer S. , Lin Dong , Lerdrup Mads , Friis Stine , Bartels Anette , Kristensen Gitte , Krzyzanowska Agnieszka , Xue Hui , Fazli Ladan , Hansen Klaus H. , Røder Martin A. , Brasso Klaus , Moreira José M. , Bjartell Anders , Wang Yuzhuo , Olsen Jesper V. , Collins Colin C. , Iglesias-Gato Diego
Published: April 2023

Table S6
Figure S3 from Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
Authors: Flores-Morales Amilcar , Bergmann Tobias B. , Lavallee Charlotte , Batth Tanveer S. , Lin Dong , Lerdrup Mads , Friis Stine , Bartels Anette , Kristensen Gitte , Krzyzanowska Agnieszka , Xue Hui , Fazli Ladan , Hansen Klaus H. , Røder Martin A. , Brasso Klaus , Moreira José M. , Bjartell Anders , Wang Yuzhuo , Olsen Jesper V. , Collins Colin C. , Iglesias-Gato Diego
Published: April 2023

Figure S3
Figure S1 from Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer
Authors: Flores-Morales Amilcar , Bergmann Tobias B. , Lavallee Charlotte , Batth Tanveer S. , Lin Dong , Lerdrup Mads , Friis Stine , Bartels Anette , Kristensen Gitte , Krzyzanowska Agnieszka , Xue Hui , Fazli Ladan , Hansen Klaus H. , Røder Martin A. , Brasso Klaus , Moreira José M. , Bjartell Anders , Wang Yuzhuo , Olsen Jesper V. , Collins Colin C. , Iglesias-Gato Diego
Published: April 2023

Figure S1
Supplementary Tables from Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for PHF10/BAF45a
Authors: Anbunathan Hima , Verstraten Ruth , Singh Arun D. , Harbour J. William , Bowcock Anne M.
Published: April 2023

Supplementary Tables
Supplementary Figures from Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for PHF10/BAF45a
Authors: Anbunathan Hima , Verstraten Ruth , Singh Arun D. , Harbour J. William , Bowcock Anne M.
Published: April 2023

Supplementary Figures 1-8
Supplemental information from Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination
Authors: Tu Yiming , Chen Zhenyao , Zhao Pengzhan , Sun Guangchi , Bao Zhongyuan , Chao Honglu , Fan Liang , Li Chong , You Yongping , Qu Yan , Chen Yun , Ji Jing
Published: April 2023

Supplemental information
Supplemental Figure S9 from Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination
Authors: Tu Yiming , Chen Zhenyao , Zhao Pengzhan , Sun Guangchi , Bao Zhongyuan , Chao Honglu , Fan Liang , Li Chong , You Yongping , Qu Yan , Chen Yun , Ji Jing
Published: April 2023

Supplemental Figure S9
Supplementary Table 7 from Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab
Authors: Keung Emily Z. , Burgess Melissa , Salazar Ruth , Parra Edwin R. , Rodrigues-Canales Jaime , Bolejack Vanessa , Van Tine Brian A. , Schuetze Scott M. , Attia Steven , Riedel Richard F. , Hu James , Okuno Scott H. , Priebat Dennis A. , Movva Sujana , Davis Lara E. , Reed Damon R. , Reuben Alexandre , Roland Christina L. , Reinke Denise , Lazar Alexander J. , Wang Wei-Lien , Wargo Jennifer A. , Tawbi Hussein A.
Published: April 2023

Comparison of tumor PD-L1 expression and tumor immune infiltrate between baseline biopsies and at 8 weeks on treatment (UPS/DDLPS only)
Supplemental Figure S6 from Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination
Authors: Tu Yiming , Chen Zhenyao , Zhao Pengzhan , Sun Guangchi , Bao Zhongyuan , Chao Honglu , Fan Liang , Li Chong , You Yongping , Qu Yan , Chen Yun , Ji Jing
Published: April 2023

Supplemental Figure S6